Added Clinical Benefit of Incorporating 2-Deoxy-2-[18F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment
- 31 August 2002
- journal article
- Published by Elsevier in Molecular Imaging & Biology
- Vol. 4 (4) , 283-293
- https://doi.org/10.1016/s1536-1632(02)00016-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: